1.2.2- Year of data: by The Pennsylvania State University CiteSeerX Archives
  1 
 
 
 
 
Structured Questionnaire 23/29 
Prevention and Reduction of Health-Related Harm associated with drug 
use 
 
 
 
1. Methodology 
 
1.1. - EMCDDA report identification 
 
1.1.1 - EMCDDA data collection year:                      
 
 
 
1.2. Report identification by NFP 
 
 
1.2.1 - Country:  
                                                                                                                                                                
 
 
 
1.2.2 - Year of data: 
                                                                                                                                                                 
 
 
 
1.2.3 - Name of the person submitting this structured questionnaire: 
                                                                                                                                                                 
 
 
 
1.2.4 - Institutional affiliation: 
                                                                                                                     
 
 
 
1.2.5 - E-mail address: 
                                                                                                           
 
 
 
1.2.6 - Other experts involved in providing information for this structured questionnaire 
                                                                                                             2 
Introduction 
The prevention and reduction of health-related harm associated with drug dependence has been the subject 
of a Council Recommendation in 2003 (2003/488/EC) and is addressed in the current EU Drugs Action 
Plan 2005 – 2008, specifically in objectives 14 to 17. 
 
Both instruments call on Member States to develop a range of specific services and facilities aiming at risk 
reduction, and to improve availability, access and quality of measures to reduce the incidence of infectious 
diseases and the number of drug-related emergencies and deaths. 
 
The tasks of the EMCDDA comprise the monitoring of the state of the drugs problem and of the responses to 
drug related problems, including harm reduction measures. The Centre is furthermore charged with the 
development of tools and instruments to improve data comparability and to facilitate the Member States’ 
and the Commission’s monitoring and evaluation of their respective policies. 
 
Objectives 
This structured questionnaire on harm reduction addresses the policies and interventions Member States 
have established to prevent and reduce health related harm associated with drug use, in particular 
infectious diseases, drug-related deaths and drug-related harm in recreational settings. It is aimed at 
collecting data on the specific policies in the field, and through which an overview of the main settings, 
approaches, and interventions used in the countries can be provided. It also covers measures to achieve 
and maintain high service provision quality. 
 
Questionnaire Structure  
A – Policies 
B – Interventions to prevent infectious diseases 
C – Interventions to prevent drug-related deaths and emergencies 
D – Interventions to prevent and reduce drug-related harm in recreational settings  
E – Quality assurance in harm reduction 
 
 
          Contact person:     
 
Dagmar Hedrich            Alessandro Pirona 
dagmar.hedrich@emcdda.europa.eu       alessandro.pirona@emcdda.europa.eu 
tel.: 00351 218 113 067           tel.: 00351 218 113 063  3 
2. A – Policies 
 
 
 
2.1. - Objective: to collect data on the specific actions being taken at national and local policy level to 
prevent health-related harm associated with drug use 
 
 
 
Policies regarding prevention of infectious diseases 
 
 
2.2. - Has your country a specific, defined written strategy
(1) for preventing drug-related 
infectious diseases among drug users, e.g. an action plan or a section in the national 
drugs strategy dedicated to the topic? 
 
(1) A strategy is a written description of a policy approach. 
 
 
2.2.1 - Defined written strategy for preventing drug-related infectious diseases: 
 
Yes, part of National Drug Strategy 
Yes, separate document 
No 
No information 
 
 
Yes, part of National Drug Strategy = go to question 2.4 
Yes, separate document = go to question 2.3 
No = go to question 2.5 
No information = go to question 2.5 
 
 
2.2.2 – Comments: 
                                                                        
 
 
2.3. - Please provide the following details for this document: 
 
 
2.3.1 - Details for document regarding prevention of infectious diseases: 
 
Title   
Year of adoption   
Timeframe (Year to Year)   
 
   4 
2.3.2 - Is the document regarding prevention of infectious diseases available on the internet? 
 
Yes 
No 
No Information 
 
 
2.3.3 - Please provide URL or source(s) [INF]: 
 
If Yes, please provide URL:   
If not, please provide source(s)   
 
 
 
2.4. - Please specify objectives of the strategy for preventing drug-related infectious 
diseases among drug users, concrete actions that are defined and target groups 
mentioned. 
 
 
2.4.1 - Objectives, concrete actions and target groups: 
                                                                        
 
 
 
2.5. - Are there specifically defined sub-national
2 strategies
3 for preventing drug-related 
infectious diseases among drug users? 
 
2 Sub-national = counties, municipalities or other regional breakdowns.  
3 Local policy approach, drawn up for a specified geographical area by a local/regional administration or other competent body. 
 
 
2.5.1 - Sub-national strategies for preventing drug-related infectious diseases: 
 
Yes 
No 
No information 
 
No = go to question 2.7 
No information = go to question 2.7 
 
 
2.5.2 – Comments:  
                                                                        
 
   5 
 
2.6. - Please provide details on the character of those, e.g. geographical scope, specific 
target groups, etc. 
 
 
2.6.1 - Details on the character of sub-national strategies [INF]: 
                                                                        
 
 
 
Policies regarding reduction of drug-related deaths 
 
 
2.7. - Has your country a specific, defined written strategy to reduce the number of 
acute drug-related deaths, e.g. an action plan or a section in the national drugs strategy 
dedicated to the topic? 
 
 
2.7.1 - Defined written strategy to reduce the number of acute drug-related deaths: 
 
Yes, part of National Drug Strategy 
Yes, separate document 
No 
No information 
 
 
Yes, part of National Drug Strategy = go to question 2.9 
Yes, separate document = go to question 2.8 
No = go to question 2.10 
No information = go to question 2.10 
 
 
2.7.2 – Comments: 
                                                                       
 
 
 
2.8. - Please provide the following details for this document: 
 
 
2.8.1 - Details of the document regarding reduction of number of acute drug-related deaths: 
 
Title   
Year of adoption   
Timeframe (Year to Year)   
 
   6 
2.8.2 - Is the document regarding reduction of acute drug-related deaths available on Internet? 
 
Yes 
No 
No information 
 
 
2.8.3 - Please provide URL or source(s) [DRD]: 
 
If Yes, please provide URL:   
If not, please provide source(s)   
 
 
 
2.9. - Please specify targets of the strategy to reduce the number of acute drug-related 
deaths and, if mentioned, specific target groups. 
 
 
2.9.1 - Targets and target groups of the strategy to reduce the number of acute drug-related deaths: 
                                                                       
 
 
 
2.10. - Are there specifically defined sub-national strategies for preventing acute drug-
related deaths among drug users? 
 
 
2.10.1 - Sub-national strategies for preventing acute drug-related deaths: 
 
Yes 
No 
No information 
 
No = go to question 2.12 
No information = go to question 2.12 
 
 
 
2.11. - Please provide details on the character of those, e.g. geographical scope, specific 
target groups, etc. 
 
 
2.11.1 - Details on the character of sub-national strategies [DRD]: 
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Policies regarding harm related to recreational drug use 
 
 
2.12. - Are there any policies referring specifically to the reduction of drug-related harm 
in recreational settings (festivals, raves, clubs, discos, parties, etc.)? 
 
2.12.1 - Harm reduction policies in recreational settings: 
 
Yes 
No 
No information 
 
No = go to question 3.1 
No information = go to question 3.1 
 
 
2.12.2 – Comments: 
                                                                       
 
 
 
2.13. - Please provide details on the character of those, e.g. geographical scope, specific 
target groups, etc. 
 
 
2.13.1 - Details on the character of policies regarding harm related to recreational drug use: 
                                                                        
 
 
 
2.14. - Are there policies applying to alcohol-related harm in those settings? 
 
 
2.14.1 - Policies applying to alcohol-related harm in recreational settings: 
 
Yes 
No 
No information 
 
 
2.14.2 - Please specify these alcohol-related harm policies: 
                                                                       
 
 
 
2.15. - Indicate sources and references to the information provided in section A.   8 
 
 
2.15.1 - Sources and references to section A: 
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3. B - Interventions to prevent infectious diseases 
 
 
3.1. - Please estimate in how far the following selected response measures to reduce the 
prevalence of infectious disease have been provided to problem drug
(4) users in the 
community over the past 12 months. 
 
(4) Problem drug use is defined by the EMCDDA as “injecting or long duration / regular use of opioids, cocaine and/or 
amphetamines”. 
 
Rating scale 
 
FULL = nearly all members of the target group have received the service during the last year at least once 
EXTENSIVE = a majority of the target group (but not nearly all of them) have received the service during the last year 
at least once 
LIMITED = more than a few members of the target group (but not a majority of them) have received the service 
during the last year at least once 
RARE = just a few members of the target group have received the service during the last year at least once 
 
 
3.1.1 - Individual counselling on infectious diseases risk. [community] 
Assessment of personal drug-related risk behaviour 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
3.1.2 - HCV
(5) testing [community] 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
5 HCV = hepatitis C virus 
 
 
3.1.3 - Practical advice and training on ‘safer use/safer injecting
(6) [community] 
   10 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
(6) This training may address the risks of sharing drug use paraphernalia, as well as motivating change 
from injecting to non-injecting (safer) routes of administration. 
 
 
3.1.4 - Needle and syringe programmes (NSPs) [community]  
(consider only subgroup drug injectors in your rating) 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
3.2. - Are peer educators
(7) involved in the response to prevent infectious diseases 
among drugs users? 
 
(7) Peer educators are former or current drug users, providing health education to current users. 
 
 
3.2.1 - Peer educator involvement: 
 
Yes 
No 
No information 
 
 
 
3.3. - Please describe the main outreach health education approaches used in your 
country with the objective to prevent infectious diseases amon drug users. 
 
 
3.3.1 - Main outreach health education approaches: 
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3.4. - Please tick three responses that are - according to your national policy - 
considered as priority responses to prevent infectious diseases among drug users. 
 
 
3.4.1 - Priority responses to prevent infectious diseases: 
 
Information materials dissemination 
Individual risk assessment and one to one counselling 
Voluntary
(8) infectious disease counselling and testing 
Outreach health education 
Provider-driven infectious disease testing 
Hepatitis vaccination programme 
Training on ‘safer use / safer injecting’ 
Needle and syringe programmes 
Other 1 (please specify below) 
Other 2 (please specify below) 
Other 3 (please specify below) 
No information 
 
(8) Voluntary counselling and testing (VCT) for HIV is internationally recognized as an effective, important strategy for both 
prevention and care. Research has found it to be a cost-effective strategy for facilitating behaviour change, and it is an important 
entry point for care and support for those who test positive. 
 
Further information on VCT. 
 
 
3.4.2 - Please describe 'Other 1' priority: 
                                                                                                          
 
 
3.4.3 - Please describe 'Other 2' priority: 
                                                                                                          
 
 
3.4.4 - Please describe 'Other 3' priority: 
                                                                                                          
 
 
3.4.5 – Comments: 
                                                                                                          
 
 
 
Testing, vaccination & treatment of infectious diseases 
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3.5. - Please estimate in how far the following selected response measures to reduce the 
prevalence of infectious diseases have been provided to prisoners over the past 12 
months. 
 
Rating scale 
 
FULL = nearly all prisoners have received the service during the last year at least once 
EXTENSIVE = a majority of prisoners (but not nearly all of them) have received the service during the last year at 
least once 
LIMITED = more than a few prisoners (but not a majority of them) have received the service during the last year at 
least once 
RARE = just a few prisoners have received the service during the last year at least once 
 
3.5.1 - Individual counselling on infectious diseases risk. [prison]  
Assessment of personal drug-related risk behaviour 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
3.5.2 - HCV testing on entry into prison 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
3.5.3 - Practical advice and training on ‘safer use / safer injecting [prison] 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
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3.5.4 - Needle and syringe programmes (NSPs) [prison]  
(consider only the subgroup of current drug injectors among prisoners in your rating) 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
3.5.5 - HCV testing on release from prison 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
3.5.6 – Comments 
                                                                                                          
 
 
 
3.6. - Is hepatitis B vaccination included in your national routine vaccination scheme 
(universal vaccination)? 
 
 
3.6.1 - Universal hepatitis B vaccination: 
 
Yes 
No 
No information 
 
 
3.6.2 - If yes: since when (year), what is the immunization schedule and is it combined with hepatitis A 
immunization [community]? 
                                                                                                          
 
 
 
3.7. - Is there a risk-group specific hepatitis B vaccination programme which covers 
problem drug users in the community?   14 
 
 
3.7.1 - Risk-group specific hepatitis B vaccination programme: 
 
Yes 
No 
No information 
 
 
3.7.2 – Comments 
                                                                                                          
 
 
 
3.8. - Is there such a programme in prisons? 
 
 
3.8.1 - Risk-group specific hepatitis B vaccination programme in prison: 
 
Yes 
No 
No information 
 
 
3.8.2 - If yes: since when (year), what is the immunization schedule and is it combined with hepatitis A 
immunization [prison]? 
                                                                                                          
 
 
3.8.3 – Comments 
                                                                                                          
 
 
 
3.9. - Are there formal
(9) training programmes regarding health promotion activities that 
should be linked to syringe exchange available to the following target groups? 
 
(9) A training programme should be considered as 'formal' if it is based on a curriculum or training 
handbook, or if it is taught by trained staff. 
 
 
3.9.1 - Formal training programmes for staff of drug agencies: 
 
Yes 
No 
No information 
 
   15 
3.9.2 - Any formal training programmes for pharmacists: 
 
Yes 
No 
No information 
 
 
3.9.3 - Any formal training programmes for prison staff: 
 
Yes 
No 
No information 
 
 
3.9.4 - Any formal training programmes for other groups (please specify below) 
 
Yes 
No 
No information 
 
 
3.9.5 - Specify the other groups receiving trainings on health promotion: 
 
 
3.9.6 – Comments 
 
 
 
3.10. - Please provide information on surveys/research investigating the role and 
attitudes of pharmacists towards syringe exchange: 
 
 
3.10.1 - References and outcomes of studies investigating the role and attitudes of pharmacists: 
                                                                                                          
 
 
 
3.11. - Please assess the level of provision of the following injecting paraphernalia at 
specialised drug agencies with NSPs
(10)  
 
(10)The acronym NSP stands for ‘needle and syringe programme’. It is used to describe the distribution or exchange sterile injecting 
paraphernalia, including syringes and hypodermic needles 
 
 
Rating scale 
 
FULL = nearly all prisoners have received the service during the last year at least once 
EXTENSIVE = a majority of prisoners (but not nearly all of them) have received the service during the last year at 
least once   16 
LIMITED = more than a few prisoners (but not a majority of them) have received the service during the last year at 
least once 
RARE = just a few prisoners have received the service during the last year at least once 
 
 
3.11.1 - The provision of alcohol pads is… 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
3.11.2 - The provision of dry wipes is… 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
3.11.3 - The provision of sterile mixing containers (cookers/spoons) is… 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
3.11.4 - The provision of small quantities of water for dissolving injectable drugs is… 
 
Full 
Extensive 
Limited 
Rare   17 
Does not exist 
No information 
 
 
3.12. - Do agencies in your country distribute an 'injecting kits'? 
 
Rating scale 
 
FULL = nearly all prisoners have received the service during the last year at least once 
EXTENSIVE = a majority of prisoners (but not nearly all of them) have received the service during the last year at 
least once 
LIMITED = more than a few prisoners (but not a majority of them) have received the service during the last year at 
least once 
RARE = just a few prisoners have received the service during the last year at least once 
 
 
3.12.1 - Level of provision of 'injecting kits': 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
No = go to question 3.15 
No information = go to question 3.15 
 
 
 
3.13. - Which items - besides syringe and needle - does the most frequently distributed 
'injecting kit' contain as a standard? 
 
 
3.13.1 - Standard content of the main 'injecting kit': 
 
Written information about safer use 
Alcohol pads 
Dry wipes 
Water for dissolving drugs 
Sterile mixing container 
Filter 
Citric / ascorbic acid 
Bleach 
Condom   18 
Other (specify) 
No information on contents available 
 
 
3.13.2 - Please specify 'other' items of the 'injecting kit' provided as a standard: 
                                                                       
 
 
 
3.14. - Please provide information on drug use paraphernalia that are provided to non-
injecting drug users in your country (target groups, setting): 
 
 
3.14.1 - Paraphernalia for non-injecting drug users; target groups, settings: 
                                                                        
 
 
 
3.15. - Indicate sources and references to the information provided in section B. 
 
 
3.15.1 - Sources and references to section B: 
                                                                          19 
4. C - Interventions to prevent acute drug-related deaths and drug-related 
emergencies 
 
 
 
4.1. - Please note that a number of effective interventions are not addressed here 
because data are collected in other EMCDDA projects (e.g. drug treatment) 
 
 
 
4.2. - Please estimate in how far the following selected response measures that aim at 
the prevention of acute drug-related deaths and problem drug-related emergencies 
have been provided to problem drug users over the past 12 months: 
 
 
Rating scale 
 
FULL = nearly all members of the target group have received the service during the last year at least once 
EXTENSIVE = a majority of the target group (but not nearly all of them) have received the service during the last year 
at least once 
LIMITED = more than a few members of the target group (but not a majority of them) have received the service 
during the last year at least once 
RARE = just a few members of the target group have received the service during the last year at least once 
 
 
4.2.1 - Overdose information materials  
(printed or multimedia) 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
4.2.2 - Individual overdose risk assessment  
 
(provided by trained drugs or health workers) 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
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4.2.3 - Overdose response training
(11) 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
(11) One-to-one or group education sessions on risks, prevention of risks and on management of overdoses. This training should 
include: information on risk situations and risky behaviour, how to recognise overdoses, and how to respond adequately (at least 
the recovery position). 
 
 
4.2.4 - (only for target group: prisoners)  
Prison pre-release counselling on overdose risk and prevention 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
 
4.3. - Are there specific information materials on prevention of acute drug-related 
deaths and drug-related emergencies available for the following groups: 
 
 
4.3.1 - Specific materials on prevention of acute drug-related deaths and drug-related emergencies 
elaborated for police officers: 
 
Yes 
No 
No information 
 
 
4.3.2 - Specific materials on prevention of acute drug-related deaths and drug-related emergencies 
elaborated for prison staff: 
 
Yes 
No 
No information   21 
 
 
4.3.3 - Specific materials on prevention of acute drug-related deaths and drug-related emergencies 
elaborated for family / friends of drug users: 
 
Yes 
No 
No information 
 
 
4.3.4 - Specific materials on prevention of acute drug-related deaths and drug-related emergencies 
elaborated for nightclub / bar staff: 
 
Yes 
No 
No information 
 
 
4.3.5 - Specific materials on prevention of acute drug-related deaths and drug-related emergencies 
elaborated for other groups 
(Please specify below): 
 
Yes 
No 
No information 
 
 
4.3.6 - Please specify other group(s), for which such specific information materials have been elaborated: 
                                                                       
 
 
 
4.4. - Risk education and overdose response training for problem drug users is provided 
in: 
 
 
4.4.1 - Provision of risk education and overdose response trainings: 
 
In nearly all relevant
(12) cities or towns 
In a majority of relevant cities (but not in nearly all of them) 
In more than a few relevant cities (but not in a majority of them) 
In just a few relevant cities 
Does not exist 
No information available 
 
(12) ‘Relevant’ = where the size of the target population is sufficient for the implementation of the intervention   22 
 
 
4.4.2 – Comments 
                                                                        
 
 
 
4.5. - Is the distribution, possession or administration of naloxone regulated in your 
country? 
 
 
4.5.1 - Regulation of Naloxone distribution, possession or administration: 
 
Yes 
No 
No information 
 
 
4.5.2 - Specify type of regulation: 
 
By law 
By administrative regulation 
Other (Please specify below) 
 
 
4.5.3 - Please specify details of response 'other' at question on regulation of naloxone distribution, 
possession or administration: 
                                                                        
 
 
 
4.6. - Is naloxone available on a "take-home" basis for drug users in your country? 
 
 
4.6.1 - Naloxone available on a "take-home" basis: 
 
Yes 
No 
No information 
 
 
4.6.2 – Comments 
                                                                        
 
 
 
4.7. - Are supervised drug consumption rooms (DCRs)
(13) available in your country? 
 
(13) other than in the framework of drug prescription programmes   23 
 
 
4.7.1 - Supervised drug consumption rooms (DCRs) available: 
 
Yes 
No 
No information 
 
No = go to Section D / question 5.1 
No information = go to Section D / question 5.1 
 
4.7.2 - Number of DCRs and supervised consumptions: 
 
  Number  Estimate 
Cities with DCRs                   No information   Yes      No 
Fixed and mobile DCR facilities                   No information   Yes      No 
Supervised drug consumptions per year 
(national total) 
                 No information   Yes      No 
 
 
 
4.7.3 - How many percent of supervised drug consumptions are injections? 
                                                                        
 
 
 
4.8. - Indicate sources and references to the information provided in section C. 
 
 
4.8.1 - Sources and references to section C: 
                                                                        24 
5. D - Interventions to prevent and reduce drug-related harm in 
recreational settings 
 
 
 
5.1. - Are there guidelines concerning the health and safety of people who attend night 
clubs, festivals, etc. and use drugs available in your country? 
 
 
5.1.1 - Guidelines concerning the health and safety of people attending night clubs, festivals etc: 
 
Yes 
No 
No information 
 
No = go to question 5.4 
No information = go to question 5.4 
 
 
5.1.2 – Comments 
                                                                                                           
 
 
 
5.2. - Please provide reference of guidelines (author, title, year, publisher), by whom 
guidelines are issued and relevant URLs for guidelines 
 
 
5.2.1 - Reference(s), by whom guidelines on interventions to prevent and reduce drug-related harm in 
recreational settings are issued and relevant URL of guidelines: 
 
 
  Reference  Issued by:  Relevant URL (http://) 
1       
2       
3       
4       
 
 
5.2.2 – Comments 
                                                                                                           
 
 
 
5.3. - Provide information whether these guidelines are monitored and enforced? 
 
 
5.3.1 - Guidelines monitored and enforced:  
[drug-related harm in recreational settings] 
   25 
Yes 
No 
No information 
 
 
5.3.2 – Comments 
                                                                                                           
 
 
 
5.4. - Please assess the level of provision of the following measures concerning the 
health and safety of people who attend night clubs/large music festivals and use drugs 
in your country. 
 
Rating scale 
 
FULL = nearly all agencies 
EXTENSIVE = a majority of agencies with NSPs provide the item (but not nearly all of them) 
LIMITED = more than a few agencies with NSPs provide the item (but not a majority of them) 
RARE = just a few agencies with NSPs provide the item  
 
Please indicate also which of these measures are featured in the guidelines reported in questions 5.1 and 
5.2. 
 
 
 
Provision of free, accessible, cold water 
 
 
5.4.1 - Provision of free, accessible, cold water in night clubs: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
5.4.2 - Provision of free, accessible, cold water in large music festivals: 
 
Full 
Extensive 
Limited 
Rare   26 
Does not exist 
No information 
 
 
5.4.3 - Provision of free, accessible, cold water featured in guidelines: 
 
Yes 
No 
No information 
Does not exist 
 
 
 
Immediate availability of First Aid at the premises (e.g. trained staff/employees) 
 
 
5.4.4 - Immediate availability of First Aid at the premises (e.g. trained staff/employees) in night clubs: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
5.4.5 - Immediate availability of First Aid at the premises (e.g. trained staff/employees) in large music 
festivals: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
5.4.6 - Immediate availability of First Aid at the premises (e.g. trained staff/employees) featured in 
guidelines: 
 
Yes 
No   27 
No information 
Does not exist 
 
 
 
Availability of ‘chill out’
(15) rooms 
 
(15) Chill out rooms: adequate rest facilities, clearly identifiable as such, which are cooler, quieter and separate from the main 
dance area(s). 
 
 
5.4.7 - Availability of ‘chill out’ rooms in night clubs: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
5.4.8 - Availability of ‘chill out’ rooms in large music festivals: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
5.4.9 - Availability of ‘chill out’ rooms featured in guidelines: 
 
Yes 
No 
No information 
Does not exist 
 
 
 
Information regarding the prevention and reduction of harm associated with 
drugs usually consumed at these premises (e.g. ecstasy, cocaine, speed, etc.) 
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5.4.10 - Information regarding the prevention and reduction of harm associated with drug use in night 
clubs: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
5.4.11 - Information regarding the prevention and reduction of harm associated with drug use in large 
music festivals: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
5.4.12 - Information regarding the prevention and reduction of harm associated with drug use featured 
in guidelines: 
 
Yes 
No 
No information 
Does not exist 
 
 
 
Promotion and integration of outreach work in premises 
 
 
5.4.13 - Promotion and integration of outreach work in night clubs: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information   29 
 
 
5.4.14 - Promotion and integration of outreach work in large music festivals: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
5.4.15 - Promotion and integration of outreach work featured in guidelines: 
 
Yes 
No 
No information 
Does not exist 
 
 
 
Amnesty
(16) bins 
 
(16) Containers placed outside clubs or festival premises and into which visitors are invited to discard illicit drugs without risking 
judicial prosecution. 
 
 
5.4.16 - Amnesty bins in night clubs: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
5.4.17 - Amnesty bins in large music festivals: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist   30 
No information 
 
 
5.4.18 - Amnesty bins are featured in guidelines: 
 
Yes 
No 
No information 
Does not exist 
 
 
 
Other 
 
 
5.4.19 - Please specify other intervention(s) to prevent and reduce drug-related harm in recreational 
settings: 
                                                                                                           
 
 
5.4.20 - Other intervention(s) in night clubs: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
5.4.21 - Other intervention(s) in large music festivals: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
5.4.22 - Other intervention(s) featured in guidelines: 
 
Yes 
No   31 
No information 
Does not exist 
 
 
5.4.23 – Comments 
                                                                                                           
 
 
 
5.5. - Please assess the level of provision of drug checking
17 in your country at night 
clubs and at festivals, raves (see rating scale under question 5.4) 
 
(17)The term “drug checking” means the chemical analysis of substances that have been obtained as drugs on the black market in 
order to assess their composition and/or purity and to inform potential users of possible health risks involved. 
 
 
5.5.1 - Level of provision of drug checking at night clubs: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
 
5.5.2 - Level of provision of drug checking at festivals, raves: 
 
Full 
Extensive 
Limited 
Rare 
Does not exist 
No information 
 
If no drug checking, go to question 6.3 
 
 
5.5.3 – Comments 
                                                                                                           
 
 
 
5.6. - Please provide the following information on drug checking 
 
 
5.6.1 - Drug checking testing is carried out on-site:   32 
 
Yes 
No 
No information 
 
 
5.6.2 - Drug checking testing is carried out off-site:  
(lab) 
 
Yes 
No 
No information 
 
 
5.6.3 – Comments 
                                                                                                           
 
 
 
5.7. - Indicate sources and references to the information provided in section D. 
 
 
5.7.1 - Sources and references to section D: 
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6. E – Quality assurance in harm reduction 
 
 
6.1. - Are there quality guidelines for the implementation of harm reduction available? 
 
Please tick boxes that apply. In case guidelines apply to a specific area (risk behaviour assessment and/or needle 
syringe exchange and/or other), you have the option to specify this further. 
 
 
Quality guidelines 
 
Guidelines are systematically developed statements to assist practitioners and patient decisions about 
appropriate interventions for specific circumstances (see also Field and Lohr, 1992). Commonly guidelines 
include a set of recommendations or steps that can be followed when implementing an intervention. For 
example, quality guidelines for treatment may refer to treatment processes e.g. guidance for binding levels 
of assessment, individual treatment planning, informed consent, pathways of care, referrals. They may also 
include evaluation processes that refer e.g. to binding documentation (entry/discharge), retention, 
supervision, evaluation of client satisfaction, staff satisfaction, outcomes. The content of guidelines are 
commonly based on the available research evidence. Quality guidelines can range from those that include 
general recommendations up to mandatory guidelines in the framework of authorisation of services. Other 
terms used are: practice guidance, clinical guidelines, guides, practice recommendations - Field MJ, Lohr 
KN (Eds). Guidelines for clinical practice: from development to use. Institute of Medicine, Washington, 
D.C: National Academy Press, 1992  
 
 
 
6.1.1 - Are there quality guidelines for assessment of infectious disease risks among drug 
users? 
 
Yes, national 
Yes, sub-national
(18) 
No 
No information available 
 
(18) Sub-national guidelines can be regional or local, or be drawn up by relevant umbrella organisations. 
 
 
6.1.2 - Are there quality guidelines for needle/syringe provision? 
 
Yes, national 
Yes, sub-national 
No 
No information available 
 
 
6.1.3 - Are there quality guidelines for assessment of overdose risk among drug users? 
   34 
Yes, national 
Yes, sub-national 
No 
No information available 
 
 
6.1.4 - Are there quality guidelines for prison pre-release counselling? 
 
Yes, national 
Yes, sub-national 
No 
No information available 
 
 
6.1.5 - Are there other harm reduction quality guidelines available?  
(Please specify below) 
 
Yes, national 
Yes, sub-national 
No 
No information available 
 
 
6.1.6 - Please specify which other guidelines are available:  
                                                                                                           
 
 
6.1.7 – Comments 
                                                                                                           
 
 
 
6.2. - If you answered yes to question 6.1, please provide reference of guidelines 
(author, title, year, publisher), by whom guidelines are issued and relevant URLs for 
guidelines. 
 
 
6.2.1 - Reference(s) of guidelines for assessment of infectious disease risks among drug users: 
 
Reference   
Issued by:   
Relevant URL (http://)   
 
 
6.2.2 - Reference(s) of guidelines for needle/syringe provision: 
 
Reference     35 
Issued by:   
Relevant URL (http://)   
 
 
6.2.3 - Reference(s) of guidelines for assessment of overdose risk among drug users: 
 
Reference   
Issued by:   
Relevant URL (http://)   
 
 
6.2.4 - Reference(s) of guidelines for prison pre-release counselling: 
 
Reference   
Issued by:   
Relevant URL (http://)   
 
 
6.2.5 - Please provide reference(s) for other harm reduction quality guidelines:  
(Please specify below) 
 
Reference   
Issued by:   
Relevant URL (http://)   
 
 
6.2.6 – Comments 
                                                                                                           
 
 
 
6.3. - Is there an authorised institution in your country which is responsible for 
developing guidelines for good practice
(19) in the field of harm reduction? 
 
 
(19) Guidelines for good practice include recommendations about interventions that are supposed to lead to preferred clients 
outcomes (good or best practices). These may or may not have a scientific evidence-base. 
 
 
6.3.1 - Institution responsible for developing good practice guidelines: 
 
Yes 
No 
No information 
 
 
6.3.2 - If yes, please provide URL and name of the institution: 
                                                                                                           
 
 
6.3.3 – Comments   36 
                                                                                                           
 
 
 
6.4. - Indicate sources and references to the information provided in section E. 
 
 
6.4.1 - Sources and references to section E: 
                                                                                                           
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for providing this information! 
 
 